Introduction {#Sec1}
============

One of the great challenges that the pharmaceutical, chemical, and allied industries face in the 21st century is the transition to a greener and more sustainable manufacturing base that minimizes, or preferably avoids, the generation of waste and the use of toxic and/or hazardous materials. Biocatalysis has many benefits to offer in this respect. Reactions can be performed in conventional reactors (no specialized equipment is needed) under mild conditions (ambient temperature and pressure, physiological pH) in an environmentally acceptable solvent (water) using a biocompatible and biodegradable catalyst (an enzyme) that is itself derived from renewable resources.

Enzymatic reactions proceed with high regio- and stereoselectivity and generally without the need for functional group activation and protection and deprotection steps required in traditional syntheses. Hence, generally speaking, enzymatic processes generate less waste than conventional synthetic routes, are more energy efficient, and provide products in higher purity. The application of modern protein engineering techniques, such as directed evolution, has enabled the optimization of their properties to fit pre-defined process parameters (Luetz et al. [@CR27]; Turner [@CR50]). In short, enzymes can be "tailor made" and can be produced on a large scale for an attractive price.

Notwithstanding all these advantages, enzymes have some drawbacks that have limited their widespread application. They often lack operational and storage stability, for example. Enzymes are complex, highly sensitive molecules with unique three-dimensional structures that are essential for their activities. Exposure to certain conditions, such as elevated temperatures or organic solvents, can lead to denaturation (unfolding) and concomitant loss of activity. Furthermore, enzymes are generally used as aqueous solutions which makes recovery and reuse problematical and can also result in contamination of the product. These obstacles can generally be overcome by immobilization of the enzyme, affording improved storage and operational stability and providing for its facile separation and reuse (Sheldon [@CR44]). Moreover, immobilized enzymes, in contrast to free enzymes which can penetrate the skin, are unlikely to cause allergic reactions.

Enzyme immobilization: an enabling technology {#Sec2}
=============================================

Immobilization can enable economically viable applications of enzymes that, for one or more of the reasons outlined above, would not have been viable using the free enzyme. It typically involves binding the enzyme to a carrier (support), such as an ion exchange resin or silica, or encapsulation in an inert carrier, affording a biocatalyst with superior operational performance compared to the free enzyme. Binding to the carrier can involve simple adsorption, e.g., via hydrophobic or ionic interactions or actual covalent bonding. A serious drawback of such carrier-bound enzymes (Cao et al. [@CR11]) in general is their low productivities (kilograms product per kilogram enzyme) owing to the large amount of non-catalytic ballast (often \>95% of the total mass). They can also be costly as some of the carriers that are used are themselves expensive materials. In contrast, immobilization by cross-linking of enzyme molecules affords carrier-free immobilized enzymes with high productivities and avoids the costs of the carrier.

Cross-linked enzymes, produced by mixing an aqueous solution of the enzyme with an aqueous solution of glutaraldehyde, were already known in the 1960s but were generally difficult to handle, gelatinous materials exhibiting low activity, poor reproducibility, and low stability and shelf life. Consequently, carrier-bound enzymes became the method of choice for the next three decades. In the early 1990s, Altus Biologics introduced the use of cross-linked enzyme crystals (CLECs) as industrial biocatalysts (Margolin and Navia [@CR29]). The methodology was applicable to a wide variety of enzymes, and CLECs exhibited excellent operational stability, controllable particle size coupled with high productivity, and facile recovery and reuse, making them ideally suited to industrial biocatalysis. However, they had one inherent limitation: the need to crystallize the enzyme, a laborious procedure requiring enzyme of high purity which meant relatively high costs.

Several years ago, we reasoned that crystallization could perhaps be replaced by precipitation of the enzyme from aqueous buffer, a simpler and less expensive method not requiring highly pure enzymes. It is well documented that the addition of salts, or water-miscible organic solvents or non-ionic polymers, to aqueous solutions of proteins leads to their precipitation as physical aggregates that are held together by non-covalent bonding (Burgess [@CR5]). Addition of water to this precipitate results in dissolution of the enzyme. In contrast, we reasoned that cross-linking of these physical aggregates, to form what is essentially a cross-linked polymer, would render them permanently insoluble while maintaining their pre-organized superstructure and hence their catalytic activity. This led us to develop (Cao et al. [@CR9]; Sheldon [@CR46]) a new class of immobilized enzymes which we called cross-linked enzyme aggregates (CLEAs). Since selective precipitation with ammonium sulfate is a commonly used method for enzyme purification (Englard and Seifter [@CR16]), the CLEA methodology essentially combines two unit processes, purification and immobilization, into a single operation. In principle, one can even take the crude enzyme extract from fermentation broth and produce the immobilized enzyme in one simple operation. Hence, one can envisage the direct immobilization of an enzyme, at the production site, without any need for intermediate work-up or purification.

Preparation of CLEAs {#Sec3}
====================

A general scheme for the preparation of a CLEA is outlined in Fig. [1](#Fig1){ref-type="fig"}. Glutaraldehyde is generally the cross-linking agent of choice as it is inexpensive and readily available in commercial quantities. It has been used for decades for cross-linking proteins. However, the chemistry is complex and not fully understood. Cross-linking occurs via reaction of the free amino groups of lysine residues, on the surface of neighboring enzyme molecules, with oligomers or polymers of glutaraldehyde resulting from inter- and intramolecular aldol condensations. Cross-linking can involve both Schiff\'s base formation and Michael-type 1,4 addition to α,β-unsaturated aldehyde moieties, and the exact mode of cross-linking is pH dependent (Migneault et al. [@CR33]; Walt and Agayn [@CR56]). Other dialdehydes, involving less complicated chemistry, can be used as cross-linkers, e.g., dextran polyaldehyde, followed by reduction of the Schiff\'s base moieties with sodium cyanoborohydride to form irreversible amine linkages (Mateo et al. [@CR30]).Fig. 1General scheme for CLEA preparation

A variation on this theme involves performing the cross-linking in the presence of a monomer that undergoes polymerization under these conditions. This results in the formation of CLEA--polymer composites with tunable physical properties. For example, if the cross-linking is performed in the presence of a siloxane, e.g., (MeO)~4~Si, the latter undergoes simultaneous polymerization to afford a CLEA--silica composite (Schoevaart et al. [@CR42]). The hydrophobic/hydrophilic properties and particle size of the latter can be tailored by manipulating the structure of the siloxane used. More recently, we have made "smart" magnetic CLEAs by conducting the cross-linking in the presence of functionalized magnetic nanoparticles. These mCLEAs can be separated by magnetic decantation or can be used in a magnetically stabilized fluidized bed, and we envisage that this will lead to novel combinations of bioconversions and downstream processing.

Optimization of the protocols for CLEA preparation, with regard to parameters such as temperature, pH, concentration, stirring rate, precipitant, additives, and cross-linking agent, is a relatively simple operation which lends itself to automation, e.g., using 96-well plates. The nature of the precipitant predictably has an important effect on the activity recovery, and hence, it is necessary to screen a number of water-miscible organic solvents and polymers such as polyethylene glycols. In the initial screening of precipitants, the amount of aggregates formed is determined, and then they are redissolved in aqueous buffer and their activities measured. However, in our experience, observation of a high activity on redissolution of the precipitate in buffer does not automatically mean that the aggregates will retain this high activity after cross-linking. Hence, the optimum precipitant may not be the one that ultimately gives the optimum CLEA. It is advisable, therefore, to choose a few precipitants which give good yields of aggregates for further screening in subsequent cross-linking.

The molar ratio of cross-linker to enzyme is important as it influences the activity, stability, and particle size of the resulting CLEA. If the ratio is too low, sufficient cross-linking does not occur, affording a CLEA that is too flexible and unstable towards leaching in water. If it is too high, too much cross-linking can result in a complete loss of the enzyme\'s flexibility and hence its activity. Since every enzyme has a unique surface structure, containing varying numbers of lysine residues, the optimum ratio has to be determined for each enzyme. With enzymes containing few or no accessible lysine residues, cross-linking may be insufficient and lead to CLEAs that are unstable towards leaching in aqueous media. One way to overcome this problem is to add polyamines, such as polyethyleneimine, which are then co-immobilized with the enzyme (Lopez-Gallego et al. [@CR25]). Problems can also be encountered in CLEA formation when the protein concentration in the enzyme preparation is low. In such cases, CLEA formation can be promoted by the addition of a second protein, such as bovine serum albumin, as a so-called proteic feeder (Shah et al. [@CR43]).

A key, cost-determining parameter of a CLEA is the activity recovery, which should preferably be close to (or more than) 100%. Ultimately, the important commercial parameter, enzyme costs per kilogram of product, is determined by how often the CLEA can be recycled. Activity recovery is simply total activity in the CLEA divided by the activity of the free enzyme charged, expressed as a percentage, and is independent of the weight of the CLEA. Thus, 100% activity recovery could be obtained with an increase or a decrease in weight of the CLEA compared to that of the free enzyme sample charged. Specific activity, on the other hand, is defined as an activity per unit weight of protein. Obviously, the activity of the free enzyme charged and that of the immobilized enzyme recovered need to be measured *under the same conditions*. This is relatively straightforward for a hydrolytic process in which the free enzyme is dissolved in water, e.g., tributyrin hydrolysis for a lipase. However, comparison becomes more problematical for a synthesis reaction in non-aqueous media where the free enzyme is not soluble. In this case, many authors compare the specific activity of the immobilized lipase with that of so-called acetone powder, obtained by precipitation of the enzyme from aqueous solution with acetone. Another possibility is to compare it with freeze-dried enzyme.

Characteristic features of CLEAs {#Sec4}
================================

Physical properties {#Sec5}
-------------------

Particle size is an important property of any heterogeneous catalyst in the context of industrial applications since it directly effects mass transfer and filterability under operational conditions. A typical particle size of CLEAs is 5--50 μm, and their filterability is generally sufficient for batch operation. As with all solid catalysts, one might expect loss of activity owing to diffusional limitations in an immobilized enzyme. However, CLEAs are highly porous materials, and we have generally not observed any diffusional limitations when using them in biocatalytic transformations commonly used in organic synthesis. In contrast, we have observed diffusional limitations in colorimetric assays which are usually very fast reactions. Consequently, activities based on such assays should be treated with caution as they may lead to the erroneous conclusion that the CLEA has a low activity in the envisaged biotransformation.

Obviously, the rate of diffusion is influenced by the particle size, and this is determined by, inter alia, the cross-linker/enzyme ratio. Optimum rates are observed with smaller particles, but practical considerations, e.g., ease of filtration, dictate the use of larger particles. This necessitates a compromise between good activity and good filterability. Particle size is influenced by certain parameters in the synthesis, such as cross-linker-to-enzyme ratio (Yu et al. [@CR60]). The particle size of a CLEA can also increase on aging (Pchelintsev et al. [@CR38]) which strongly suggests that the cross-linking process was not complete when the reaction was stopped. However, continuous operation over a packed bed of biocatalyst will require relatively large particles in order to avoid a large pressure drop over the column. One approach to preparing CLEAs with increased particle size and enhanced mechanical stability is to encapsulate them in a polyvinyl alcohol matrix (so-called Lentikats). This results in a minor dilution of activity that was deemed acceptable (Wilson et al. [@CR57]).

One can envisage the use of smaller particles in a fluidized bed which requires particles of sufficient density that they are not blown out of the column. Alternatively, magnetic CLEAs can be held in place in a magnetically stabilized bed. Similarly, other physical attributes that effect recovery, handling, and recyclability, such as hardness, density, porosity, and robustness of the CLEA particles, can be modified by preparing the silica--CLEA composites (see earlier) with varying hydrophobicity and particle size.

Operational stability {#Sec6}
---------------------

The main reason for immobilizing an enzyme is probably the significant enhancement of operational stability towards heat and organic solvents that is generally achieved. This is a direct result of the decrease in flexibility which suppresses the propensity of enzymes towards unfolding and accompanying loss of tertiary structure necessary for activity. Indeed, we have found that immobilization of enzymes as cross-linked enzyme aggregates can lead to dramatic increases in operational stability at elevated temperatures. For instance, the limited thermal stability of papain (the protease from *Carica papaya*) is well documented. As shown in Fig. [2](#Fig2){ref-type="fig"}, the stability of a papain--CLEA, in *N*-Bz-Arg-OEt hydrolysis at pH 7 and 50°C, was dramatically enhanced compared to the free papain (Sorgedrager et al. (unpublished results)).Fig. 2Thermal stability of papain--CLEA

A characteristic feature of many multimeric enzymes is their lack of thermal stability outside the cell owing to facile multimer dissociation with concomitant loss of activity. Nitrile hydratases (NHases), for example, constitute a class of industrially important enzymes (DiCosimo [@CR14]; van Pelt et al. [@CR53]) that are notoriously unstable outside the cell. Consequently, NHase-mediated industrial biotransformations, such as acrylamide and nicotinamide manufacture from the corresponding nitriles, are limited to whole cell processes. We found that immobilization of a nitrile hydratase from an alkaliphilic bacterium, *Nitriliruptor akaliphilus*, as a CLEA led to a dramatic increase in storage stability compared to the free enzyme as shown in Fig. [3](#Fig3){ref-type="fig"} (van Pelt et al. [@CR54]).Fig. 3Storage stability of NHase at 21°C

Recyclability {#Sec7}
-------------

Another important reason to immobilize an enzyme is to facilitate its recovery from the reaction medium and subsequent reuse, resulting in simplification of downstream processing and reduction in enzyme cost contribution to the product. In our experience, CLEAs are eminently recyclable. For example, the effect of recycling on the performance of the (*R*)-oxynitrilase--CLEA from *Prunus amygdalus* in the hydrocyanation of *o-*chlorobenzaldehyde is illustrated in Fig. [4](#Fig4){ref-type="fig"}. The CLEA was recycled ten times with negligible loss in activity (van Langen et al. [@CR52]).Fig. 4Recyclability of (*R*)-hydroxynitrile lyase--CLEA in *o*-chlorobenzaldehyde hydrocyanation

Similarly, the NHase--CLEA described above was recycled 36 times in the hydration of n-hexyl cyanide. The observed loss of selectivity can probably be largely attributed to mechanical losses that inevitably occur on pipetting the supernatant from the solid CLEA (van Pelt et al. [@CR54]).

Reactor design {#Sec8}
==============

The application of immobilized enzymes in the pharmaceutical and fine chemical industries generally involves batch processes with recovery by filtration or centrifugation. In other industries, such as the conversion of oils and fats, a packed bed of CLEA in continuous operation mode may be the method of choice. This generally requires a compromise with regard to particle size to avoid the large pressure drop over the column observed with small particles without the lower activities due to diffusion limitations in large particles. Alternatively, a fluidized bed of small particles can be used, but they must be relatively dense. We have also described the successful use of a penicillin amidase CLEA in a so-called filter slurry reactor for the continuous hydrolysis of penicillin G (Sorgedrager et al. [@CR48]). An interesting recent elaboration of the CLEA methodology is the development of magnetic CLEAs by performing the cross-linking in the presence of functionalized magnetic nanoparticles (unpublished results). The resulting magnetic CLEAs can be separated by magnetic decantation or can be used in a magnetically stabilized fluidized bed. The use of CLEAs in microchannel reactors has also been described (Hickey et al. [@CR18]).

Scope of the technology {#Sec9}
=======================

The CLEA technology has broad scope (Sheldon [@CR45]) and has been applied to an increasingly wide selection of hydrolases, oxidoreductases, and lyases (see Table [1](#Tab1){ref-type="table"}). The majority of CLEAs that have been described involve hydrolases, probably because they are the enzymes that have the most industrial applications and are the simplest enzymes to work with. Multipurpose CLEAs can be prepared from crude enzyme extracts consisting of multiple enzymes. For example, a multi-CLEA prepared from a porcine pancreatic acetone powder, containing lipase, phospholipase A~2~, and α-amylase enzymes, retained all three enzyme activities (Dalal et al. [@CR13]). In contrast, we use the term combi-CLEA for deliberate co-immobilization of two or more enzymes in a single CLEA for the sole purpose of performing two or more biotransformations in a multi-enzyme cascade process (see later for examples).Table 1Examples of enzymes that have been successfully cleatedHydrolases^a^Oxidoreductases^a^Lyases^a^Lipases (18)Keto reductaseHydroxynitrile lyases (6)Esterases (3)Formate dehydrogenasePyruvate decarboxylaseProteases (7)Glucose oxidaseDeoxyribose aldolaseNitrilases (2)Galactose oxidaseNitrile hydrataseAmidases (4)Amino acid oxidasePhytaseLaccaseTransferasesGalactosidaseCatalaseTransaminasesCarbonic anhydraseChloroperoxidaseAmylaseHorse radish peroxidase^a^Figures in parentheses represent the number of enzymes in this class that have been successfully cleated

Hydrolase CLEAs {#Sec10}
===============

Protease CLEAs {#Sec11}
--------------

We have prepared CLEAs from a variety of proteases, including (chymo)trypsin (E.C. 3.4.21.1), papain (E.C.3.4.22.2), and the inexpensive alkaline protease from *Bacillus licheniformis* (alcalase, E.C. 3.4.21.62, also known as subtilisin Carlsberg) used in laundry detergents. Alcalase has been widely used in organic synthesis, e.g., in the resolution of (amino acid) esters, and amines and peptide synthesis. We have demonstrated that the alcalase--CLEA has excellent storage and operational stability. It is not surprising, therefore, that alcalase--CLEA has been used in the synthesis of amino acid derivatives and peptides in organic solvents, notably methyl tert--butyl ether (Nuijens et al. [@CR35]).

A novel application of protease--CLEAs, for which long-term stability is essential, is as an environmentally acceptable substitute for organotin anti-fouling agents in paint used in marine applications. The use of toxic organotin reagents has been banned in the EU since 2008. The stabilities of CLEAs of proteases were tested in artificial seawater (ASW) both as it is and as a component of the paint (Skovgaard et al. [@CR47]). All of the protease CLEAs showed excellent tolerance to xylene and had great stability in dried paint. Furthermore, the alcalase--CLEA exhibited 900% activation during storage in ASW in dried paint. In contrast, the free alcalase lost more than 90% of its activity in 28 days in the paint. This would appear to offer great potential for the application of protease--CLEAs and perhaps CLEAs of other enzymes as anti-fouling agents in a variety of coatings.

Amidase CLEAs {#Sec12}
-------------

Our initial studies of CLEAs were concerned with penicillin G amidase (E.C. 3.5.1.11), an industrially important enzyme used in the synthesis of semi-synthetic penicillin and cephalosporin antibiotics. The limited thermal stability and low tolerance to organic solvents of the free enzyme make it an ideal candidate for stabilization as a CLEA. Indeed, penicillin G amidase CLEAs have been shown to be extremely effective catalysts, with high volumetric productivities for the hydrolysis of penicillin G and the synthesis of semi-synthetic penicillins (Cao et al. [@CR9], [@CR10]; Illanes et al. [@CR20]) and cephalosporins (Illanes et al. [@CR21], [@CR22]; Wilson et al. [@CR59]) such as ampicillin and cephalexin, respectively (see Fig. [5](#Fig5){ref-type="fig"}).Fig. 5Synthesis of ampicillin and cephalexin with pen G amidase--CLEA

The aminoacylase (EC 3.5.1.14) derived from *Aspergillus melleus* is used in the Evonik process for the manufacture of (*S*)-amino acids such as (*S*)-methionine by highly enantioselective hydrolysis of the corresponding *N*-acetyl amino acid (Fig. [6](#Fig6){ref-type="fig"}). We prepared a CLEA from this enzyme and showed it to be an active and recyclable catalyst for this reaction (Bode et al. [@CR3]). Similarly, Dong and coworkers prepared an *A. melleus* aminoacylase CLEA by coprecipitation with bovine serum albumin (BSA) as a proteic feeder and cross-linking with glutaraldehyde (Dong et al. [@CR15]). They observed 82% activity recovery, compared to 24% observed in the absence of added BSA, which was attributed to the low number of surface amino groups in the enzyme. The aminoacylase--BSA--CLEA retained more than 80% of its activity after ten cycles in the enantioselective hydrolysis of racemic *N*-acetyl methionine, demonstrating its robustness under operational conditions.Fig. 6Aminoacylase catalyzed resolution of *N*-acylamino acids

A CLEA was prepared from a crude cell-free extract of *Rhodococcus erythropolis* amidase using BSA as a proteic feeder and cross-linking with glutaraldehyde (Park et al. [@CR37]). It catalyzed the enantioselective hydrolysis of 4-chloro-3-hydroxybutyramide, albeit in low enantioselectivity (60% enantiomeric excess (ee) at 65% conversion).

Lipase and esterase CLEAs {#Sec13}
-------------------------

Lipases (E.C. 3.1.1.3) are used in a broad palette of industrial applications. It is not surprising, therefore, that a variety of lipase--CLEAs have been prepared and used as robust, recyclable catalysts in organic synthesis (Lopez-Serrano et al. [@CR26]). For example, *Candida antarctica* lipase B (CaLB) is widely used in industrial organic synthesis, and we have shown that CaLB--CLEA is completely stable towards leaching in aqueous media. Furthermore, CaLB--CLEAs exhibited performed admirably in organic solvents and in supercritical carbon dioxide (Hobbs et al. [@CR19]).

Similarly, lipase--CLEAs have been prepared from, inter alia*, C. antarctica* lipase A (Özdemirhan et al. [@CR36]), *Burkholderia cepacia* (formerly known as *Pseudomonas cepacia*) (Kumari et al. [@CR24]; Majumder et al. [@CR28]; Hara et al. [@CR17]), *Candida rugosa* (Yu et al. [@CR60]; Kartal et al. [@CR23]), and a *Pseudomonas* sp. lipase (Zhao et al. [@CR61]).[1](#Fn1){ref-type="fn"}

In contrast to the extensive studies devoted to lipase CLEAs, little attention has been paid to other esterases. CLEAs have been prepared from feruloyl esterase (E.C. 3.1.1.73) (Vafiadi et al. [@CR51]) and acetylxylan esterase (Montoro-Garcia et al. [@CR34]), enzymes that play a key role in the degradation of lignocellulose and, consequently, are of commercial importance in the context of biomass conversion processes. In vitro, the latter enzyme catalyzes the hydrolysis of the acetate moiety in cephalosporin C and 7-aminocephalosporanic acid to form advanced intermediates for the production of semi-synthetic cephalosporins (Montoro-Garcia et al. [@CR34]).

Glycosidase CLEAs {#Sec14}
-----------------

Glycosidases constitute a diverse and industrially very important class of enzymes that play a vital role in carbohydrate chemistry, for example in the in vivo hydrolysis of biopolymers such as starch, inulin, and (lingo) cellulose. They include, for example, amylases, xylanases, pectinases, and cellulases. The latter are currently the focus of much attention in connection with the pretreatment of lignocellulose in the manufacture of second generation biofuels from biomass. CLEAs have been successfully prepared from selected glycosidases. For example, we have successfully prepared a galactosidase--CLEA (Schoevaart et al. [@CR41]) with excellent operational stability and recyclability for use in the hydrolysis of lactose in dairy products and the conversion of lactose to lactulose or the synthesis of galacto-oligosaccharides for use as prebiotic food additives.

Oxidoreductase CLEAs {#Sec15}
====================

Oxidase CLEAs {#Sec16}
-------------

Glucose oxidase (GOD; E.C. 1.1.3.4) is a flavin-dependent oxidase that catalyzes the aerobic oxidation of [d]{.smallcaps}-glucose to gluconic acid with concomitant production of one equivalent of hydrogen peroxide (Bankar et al. [@CR2]). GOD is exploited in a variety of industrial applications including glucose removal from dried egg; oxygen removal from fruit juices, canned beverages, and mayonnaise; and improvement of color, flavor, and shelf life of foods. It is also used in conjunction with catalase in many of these applications and in biosensors for the detection of glucose in body fluids and industrial solutions. Most commercially available GOD is produced from *Aspergillus niger* and is essentially a byproduct of gluconic acid production. As GOD is often used in conjunction with catalase, co-immobilization of GOD with catalase has been the subject of extensive investigation. Consequently, we prepared a combi-CLEA, by coprecipitation of the two enzymes and cross-linking with glutaraldehyde, and showed that it had excellent activity retention and could be recycled without loss of activity (Schoevaart et al. [@CR41]). Similarly, we prepared a combi-CLEA from galactose oxidase (a copper-dependent oxidase) and catalase and showed that it was effective in catalyzing the aerobic oxidation of [d]{.smallcaps}-galactose to the corresponding 6-aldehyde (Schoevaart et al. [@CR41]).

Another interesting oxidase, from the viewpoint of industrial applications, is the multicopper oxidase, laccase (polyphenoloxidase, EC 1.10.3.2), a lignin-modifying enzyme that catalyzes the oxidation of phenolic compounds and aromatic amines. Over the last two decades the use of laccase has been explored for the bioremediation of xenobiotics such as endocrine-disrupting compounds (EDCs), for bleaching in the pulp and paper industry, and for decolorization of azo dyes in the textile industry. However, the application of laccase in free form (in solution) for the treatment of EDCs and azo dyes is not economically viable owing to poor operational stability and lack of reusability. One approach to overcoming these obstacles and hence to enabling an economically viable technology is to immobilize the laccase. Immobilization of laccase on solid supports significantly enhances its stability towards denaturation under operating conditions and allows for continuous processing but, at the same time, results in low productivities owing to the large percentage of non-catalytic mass in the catalyst. In stark contrast, immobilization of laccase as CLEAs affords an immobilized catalyst that combines enhanced operational stability and reusability with productivities close to those of the free enzyme (Schoevaart et al. [@CR42]; Matijosyte et al. [@CR32]). This provides a sound basis for the development of cost-effective, laccase-based processes for use in industrial and environmental biotechnology applications (Cabana et al. [@CR6]).

Furthermore, laccase can be used in conjunction with a mediator, commonly the stable free radical, TEMPO, or a derivative thereof, for the oxidation of simple alcohols. For example, laccase/TEMPO catalyzes the selective aerobic oxidation of starch to carboxystarch (Fig. [7](#Fig7){ref-type="fig"}). The latter is of interest as an environmentally friendly water superabsorbent to replace the poorly biodegradable polyacrylates currently used. Unfortunately, the enzyme costs are prohibitively high as a result of the poor stability of the laccase which undergoes suicide inactivation under the oxidizing conditions. We reasoned that the stability of laccase under operating conditions could probably be improved by removing reactive amino groups on the enzyme surface by cross-linking with glutaraldehyde. Indeed, we prepared laccase--CLEAs and showed that they had enhanced operational stability compared to the free enzymes (Schoevaart et al. [@CR42]), thus paving the way for an economically viable aerobic oxidation of starch to carboxystarch.Fig. 7Aerobic oxidation of starch to carboxystarch catalyzed by laccase/TEMPO

Tyrosinase (E.C. 1.14.18.1) is a copper-dependent oxidase with properties very similar to laccase. It catalyzes the ortho-hydroxylation of phenols and has potential applications in the same areas as for laccase. A CLEA was prepared from mushroom tyrosinase with 100% activity recovery, via precipitation with ammonium sulfate and cross-linking with glutaraldehyde (Aytar and Bakir [@CR1]). It exhibited enhanced thermal stability, both on storage and under operational conditions, compared to the free enzyme.

Peroxidase CLEAs {#Sec17}
----------------

An additional benefit of the CLEA technology is that it can stabilize the quaternary structures of multimeric enzymes, a common structural feature of many heme peroxidases, towards dissociation and loss of activity. For example, the stability of CLEAs from two tetrameric catalases (E.C. 1.11.1.6) exhibited improved stability compared to the free enzyme (Wilson et al. [@CR58]). Similarly, the thermal stability of a CLEA prepared from royal palm (*Roystonea regia*) peroxidase was 5,000-fold better than the free enzyme. The peroxidase CLEA could be used several times in the decolorization of wastewater containing azo dyes. A CLEA was also successfully prepared from horse radish peroxidase with 83% activity recovery (Sulek et al. [@CR49]). Potential applications are foreseen in the biosensor field.

The heme-dependent chloroperoxidase (CPO, E.C.1.11.1.10) from *Caldariomyces fumago* catalyzes in vivo the oxidation of chloride ion to hypochlorite, by hydrogen peroxide. In the absence of chloride ion, it catalyzes a variety of regio- and enantioselective oxygen transfer processes of synthetic interest. However, a major drawback of CPO is its low stability owing to the facile oxidative degradation of the porphyrin ring by hydrogen peroxide even at relatively low peroxide concentrations. A CLEA was successfully prepared from CPO in 68% activity recovery under optimized conditions (Perez et al. [@CR39]). It exhibited enhanced thermal stability and tolerance towards hydrogen peroxide during the sulfoxidation of anisole.

Lyase CLEAs {#Sec18}
===========

Nitrile hydratase CLEAs {#Sec19}
-----------------------

NHases (E.C. 4.2.1.84) are Fe- or Co-dependent metalloenzymes that catalyze several industrially important processes involving the hydration of nitriles to the corresponding amides (van Pelt et al. [@CR53]). They are often multimeric enzymes that have limited stability outside the cell, possibly owing to dissociation. Hence, they are generally employed in whole cell processes. We reasoned that CLEA formation could have a beneficial effect by holding the catalytically active multimer together, analogous to that observed with catalase (see above). This indeed proved to be the case. As noted above, a CLEA prepared from a NHase isolated from an alkaliphilic bacterium showed much improved operational stability, and excellent activity was observed in the conversion of acrylonitrile to acrylamide and a variety of aliphatic nitriles (van Pelt et al. [@CR54]).

Hydroxynitrile lyase CLEAs {#Sec20}
--------------------------

Hydroxynitrile lyases (E.C. 4.1.2.10) catalyze the enantioselective hydrocyanation of a wide range of aldehydes. For example, CLEAs prepared from the (*R*)-specific oxynitrilase from almonds, *P. amygdalus* (PaHnL), by cross-linking with glutaraldehyde or dextran polyaldehyde, were highly effective catalysts for the hydrocyanation of aldehydes under microaqueous conditions and could be recycled several times without loss of activity (van Langen et al. [@CR52]). Similarly, a CLEA of the relatively unknown (*R)*-selective hydroxynitrile lyase from *Linus usitatissimum* (*Lu*HNL) was used in the conversion of butanone to the *R*-cyanohydrin with 87% ee (Cabirol et al. [@CR8]). CLEAs were also prepared from the (*S*)-specific hydroxynitrile lyases from *Manihot esculenta* and *Hevea brasiliensis* (Cabirol et al. [@CR7]; Chmura et al. [@CR12]). High enantioselectivities were obtained in the hydrocyanation of pyridine-3-aldehyde (Fig. [8](#Fig8){ref-type="fig"}) using CLEAs of the (*R*) or (S)-specific hydroxynitrilases (Roberge et al. [@CR40]). The latter is a difficult substrate for enantioselective hydrocyanation owing to the relatively facile non-enzymatic background reaction as a result of the electron-attracting properties of the pyridine ring. The high enantioselectivities observed with the HnL--CLEAs could not be obtained with the free enzyme or any other immobilized form.Fig. 8Enantioselective hydrocyanation of pyridine 3-aldehyde with HNL--CLEAs

Catalytic cascades and combi-CLEAs {#Sec21}
==================================

Catalytic cascade processes have numerous potential benefits in the context of industrial production (Bruggink et al. [@CR4]). They involve fewer unit operations, less reactor volume, higher volumetric and space--time yields, and shorter cycle times and generate less waste compared to more conventional multi-step processes. By coupling steps together, unfavorable equilibria can be driven towards completion. Biocatalytic processes are ideally suited for combination in cascade processes because they are performed under roughly the same conditions of temperature and pressure. We have already mentioned (see earlier) the co-immobilization of catalase and glucose oxidase or galactose oxidase in combi-CLEAs. We recently used (Chmura et al., manuscript in preparation; Mateo et al. [@CR31]) a combi-CLEA containing the *M. esculenta* hydroxynitrile lyase, in combination with a nitrilase and an amidase, to catalyze the formation of *S-*mandelic acid in 99% ee at 96% benzaldehyde conversion (Fig. [9](#Fig9){ref-type="fig"}). The enantioselectivity is provided by the HNL, and in situ conversion by the nitrilase serves to drive the equilibrium of the first step towards product. The amidase was necessary to catalyze the hydrolysis of the amide byproduct formed in the nitrilase step. Similarly, a combi-CLEA comprising the *M. esculenta* hydroxynitrile lyase and the alkaliphilic nitrile hydratase from *N. akaliphilus* (EC 4.2.1.84) catalyzed the one-pot conversion of aldehydes to (*S)*-α-hydroxycarboxylic acid amides (van Pelt et al. [@CR55]).Fig. 9One-pot conversion of benzaldehyde to (*S*)-mandelic acid with a triple decker CLEA

Summary and future outlook {#Sec22}
==========================

Enzymes have many attractive features in the context of sustainable technologies. They are derived from renewable materials, are biodegradable, and catalyze a wide variety of processes in water at ambient temperature and pressure, without the need for protection/deprotection and activation steps that characterize many traditional syntheses. However, for commercial viability, it is often necessary to immobilize the enzyme in order to achieve improved stability and facilitate recovery and reuse. The CLEA methodology has several additional advantages compared to alternative methods for immobilization of enzymes. It is simple and does not require highly pure enzymes. Indeed, it constitutes a combination of purification and immobilization into one operation and, in the optimum scenario, can be performed with cell lysates obtained directly from fermentation broth, which translates to low costs and short time to market. It has a broad scope and affords robust, recyclable catalysts that exhibit high activity retention, enhanced thermal stability, better tolerance to organic solvents, and enhanced resistance to autoproteolysis. The technique has been successfully applied to a broad range of enzymes. Combi-CLEAs containing two or more enzymes have been prepared and used advantageously in catalytic cascade processes. Indeed, we have only been scratching at the surface regarding the potential applications of CLEAs. We believe that CLEAs will be widely applied in the future development of sustainable products and processes for the chemical and allied industries.
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Lipase--CLEA discovery platforms can be obtained from CLEA Technologies ([www.cleatechnologies.com](http://www.cleatechnologies.com)).
